How many insider declarations has Inscobee Inc. filed?

Inscobee Inc. has filed 2 public insider declarations with SEC (Form 4).

What is Inscobee Inc.'s role?

Inscobee Inc.'s reported role is not specified by the regulator across the filings.

Which companies does Inscobee Inc. report trades for?

Inscobee Inc. reports trades for Apimeds Pharmaceuticals US, Inc..

What is Inscobee Inc.'s declared buy vs sell volume?

Across the available history, declared buys total 1.8M€ and disposals 0.

← Executives ★ Sign in to follow

II

Inscobee Inc.

·SEC (Form 4)

Apimeds Pharmaceuticals US, Inc.

0

申报总数

0

公司

€180万

▲ 买入（1 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

1

已披露卖出

0

T+90 胜率

0%

T+90 平均收益

-6.4%

基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。

信号历史

Explore the full record of transactions filed by Inscobee Inc.. Insider active across 1 company, notably Apimeds Pharmaceuticals US, Inc.. Aggregated, 2 reports have been logged. Split: 1 buy · 0 sell. Total volume traded: €1.8m. Activity tracked since 12 May 2025. The latest transaction was filed on 12 May 2025 (C). Regulator: SEC (Form 4). All data is openly available.

Companies and markets linked to Inscobee Inc.

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Apimeds Pharmaceuticals US, Inc. (US)

申报2 总计

●

Inscobee Inc.

高管2025年5月12日Apimeds Pharmaceuticals US, Inc.

US$184,8347SEC ↗

71,090 股@ US$2.608.5% 占其流量Common Stock, par value $0.01 per shareSEC:0001474506-25-000109:0

▲

Inscobee Inc.

高管2025年5月12日Apimeds Pharmaceuticals US, Inc.

US$200万29SEC ↗

500,000 股@ US$4.00100.0% 占其流量Common Stock, par value $0.01 per shareSEC:0001474506-25-000089:0

标准退出：2025年8月10日 (T+90)

2 条申报中的 2 条

InsidersTradesSigma

← Executives ★ Sign in to follow

II

Inscobee Inc.

·SEC (Form 4)

Apimeds Pharmaceuticals US, Inc.

0

申报总数

0

公司

€180万

▲ 买入（1 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

1

已披露卖出

0

T+90 胜率

0%

T+90 平均收益

-6.4%

基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。

信号历史

Explore the full record of transactions filed by Inscobee Inc.. Insider active across 1 company, notably Apimeds Pharmaceuticals US, Inc.. Aggregated, 2 reports have been logged. Split: 1 buy · 0 sell. Total volume traded: €1.8m. Activity tracked since 12 May 2025. The latest transaction was filed on 12 May 2025 (C). Regulator: SEC (Form 4). All data is openly available.